← Journal/16 May 2026·3 min de lecture
THC and CBD: what are the molecular and effect differences?
Par The Phytogrammes team ·
THC and CBD are two cannabinoids produced by the same plant, Cannabis sativa L., with a similar chemical formula but a different molecular arrangement. This structural difference explains why THC is psychoactive, binding strongly to the CB1 receptors in the brain, whereas CBD is not, owing to a far more indirect interaction with those same receptors.

A common chemical origin, two different molecules
THC and CBD share the same molecular formula, C21H30O2, but their atoms are arranged differently. This difference, seemingly minimal on a molecular scale, radically changes the way each molecule fits into the CB1 and CB2 cannabinoid receptors. Both derive from a common precursor, CBGA, transformed by specific plant enzymes as the plant matures.
How THC produces a psychoactive effect
THC binds strongly and directly to the CB1 receptor, found mainly in the central nervous system. This binding activates the receptor and triggers the effects sought after or feared depending on the context: euphoria, altered perception of time, changes in appetite, impaired motor coordination at high doses. It is this direct, powerful activation that sets THC apart from almost every other hemp cannabinoid.
Why CBD does not have this effect
CBD has a much weaker affinity for the CB1 receptor, and acts mainly indirectly, by modulating the activity of other signalling systems, notably serotonergic ones, rather than by directly activating the cannabinoid receptors. Some preclinical data even suggest that CBD might attenuate certain effects of THC when the two are present together, a line of enquiry still under scientific investigation and not validated for recommended use.
THCA and decarboxylation: the chemistry behind the transformation
In the fresh plant, THC exists in an acidic form, THCA, which is not psychoactive. It is heat, through combustion, vaporisation or cooking, that triggers decarboxylation, a chemical reaction that releases a molecule of CO2 and converts THCA into active THC. The same mechanism exists for CBD, whose acidic form is CBDA. This transformation explains why a raw, unheated flower does not produce a psychoactive effect comparable to a smoked or vaporised flower.
Reported effects, between research and caution
Pharmacological research on CBD is progressing, but remains largely preclinical or limited to underpowered trials for most of the uses mentioned in the mainstream press. No health claim has been validated by EFSA for CBD outside the medicine Epidyolex, reserved for certain severe childhood epilepsies on hospital prescription. CBD is not a medicine: if in doubt, consult a healthcare professional. For an overview of hemp cannabinoids, see our complete definition.
Frequently asked questions
Can CBD turn into THC in the body?
A chemical conversion of CBD into THC has been observed in the laboratory under extreme acidic conditions, but no solid data demonstrate this phenomenon to any significant degree in the human stomach at usual doses.
Why do some hemp varieties contain more THC than others?
It is a genetic question: each variety has a different enzyme profile, which determines the proportion of CBGA converted into CBDA, THCA or CBCA during flowering.
Can CBD neutralise the effects of THC?
Preclinical data point to possible modulation, but nothing allows anyone to state that CBD reliably cancels out or offsets the effects of THC in humans.
Is a raw CBD flower psychoactive?
No. Without heat, THC remains in its acidic THCA form, which is not psychoactive. It is combustion or vaporisation that triggers the transformation into active THC.
Written by the Phytogrammes team
Every article in this journal draws on primary sources (ANSM, EFSA, EUR-Lex, peer-reviewed publications) and on the lab's own practice: batch-by-batch HPLC analyses, measured cannabinoid profiles. Our approach.
Article published on . CBD is not a medicine.
Phytogrammes products that pair well
Further reading

thcjd·16 May 2026
THCJD: what is this synthetic cannabinoid?
A synthetic molecule with an octyl chain that has appeared on foreign markets, THCJD does not occur naturally in hemp and remains outside the legal framework in France.

thcp·16 May 2026
THCP: the molecule banned in France since 2024
Discovered in 2019, THCP shows a strong affinity for CB1 receptors in the laboratory. The ANSM has classified it as a narcotic in France since June 2024.

thcpo·16 May 2026
THCPO: a synthetic ester of THCP, banned in France
THCPO is an ester derivative of THCP, obtained by chemical synthesis, with no natural existence in hemp and no place in the French legal framework.



